Vir Biotechnology (VIR) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Vir Biotechnology (VIR) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Vir Biotechnology

· VIR

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

1.802 B

+4.98%

General

Market Cap: $1.8B
Enterprise Value: $1.7B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 170.01%
Operating Margin: -88.97%
Net Profit Margin: -83.00%
FCF Margin: -109.34%
ROA: -20.72%
ROE: -29.99%
ROIC: -23.89%
Current Ratio: 6.04
Debt-to-Equity: 0.09
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 6.22
P/FCF: —
P/B: 1.92
EV/EBITDA: -6.96

Growth

Rev 1Y: -7.61%
Rev 1Y Fwd Est: 257.73%
Rev 3Y (CAGR): -65.12%
Rev 5Y (CAGR): 0.39%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $303.23M
Gross Margin: 170.01%
Operating Expenses: $785.29M
Operating Income: -$269.77M
Net Profit: -$251.68M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $278.73M
Working Capital: $478.78M
Total Assets: $1.21B
Net Debt: -$185.46M
Total Liabilities: $232.31M
Total Equity: $982.49M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$334.89M
Cash Flow from Investing: -$46.38M
Cash Flow from Financing: $404.56M
Free Cash Flow: -$331.54M
Capital Expenditures: -$3.36M